Mary Lazar MD in Royal Oak, Michigan

Medical School: Sorry, her university is not listed
Graduation Year: 1986
The Primary Medical Specialty for Mary Lazar MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 5890763650
NPI #: 1255313219
NPI Created On: 11/16/2005
NPI Last Updated Listed as: 07/12/2010
Primary Taxonomy Code: 207RC0000X
License Number:
4301055272
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Molina Healthcare of Michigan, Inc.
• Humana
• McLaren Health Plan Community
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Doppler ultrasound study of heart blood flow, valves, and chambers
7. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
8. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Initial hospital inpatient care, typically 70 minutes per day
13. Subsequent hospital inpatient care, typically 25 minutes per day
14. Subsequent hospital inpatient care, typically 35 minutes per day
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg